<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00722878</url>
  </required_header>
  <id_info>
    <org_study_id>08-0764</org_study_id>
    <secondary_id>U54HL096458</secondary_id>
    <secondary_id>RDCRN 5903</secondary_id>
    <nct_id>NCT00722878</nct_id>
  </id_info>
  <brief_title>Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung Disease</brief_title>
  <official_title>Early Onset and Progression of Primary Ciliary Dyskinesia Lung Disease Prior to 10 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary ciliary dyskinesia (PCD), also known as Kartagener syndrome, is a genetic disorder of
      the cilia, which are microscopic hair-like cells. Cilia work to keep the respiratory system
      clean by moving mucus that contains debris to the large airways, where it can be coughed out.
      People with PCD have cilia that do not move properly and therefore are not effective in
      cleaning the respiratory system. This study will determine when PCD starts and how it changes
      over time, specifically in terms of how well the lungs work, what germs grow in lung
      secretions, and how the lungs look on computed tomography (CT) scans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PCD, or Kartagener syndrome, is a genetic disorder that causes hair-like cells called cilia
      to move improperly, or in some cases, not at all. Cilia are needed to help clear the
      respiratory system of pollutants. When they work properly, they move debris-filled mucus into
      the large airways, allowing the debris to be coughed out of the body. When the cilia do not
      work properly, the body cannot rid itself of debris and is left vulnerable to serious
      infections in the sinuses, ears, and lungs. Over time, repeated infections can lead to
      scarring and permanent obstruction of these body areas. This study will determine when PCD
      starts and how it changes over time, specifically in terms of how well the lungs work, what
      germs grow in lung secretions, and how the lungs look on CT scans. This research may lead to
      a better understanding of PCD and thereby help doctors improve clinical management of the
      disease.

      Children in this study will attend six study visits over 5 years. At the first visit, parents
      will review their child's medical and cough history with doctors. Also at this visit,
      children will undergo a physical exam that will include measures of temperature, blood
      pressure, heart rate, respiration rate, and oxygen saturation level. Additional procedures
      will include collection of a respiratory mucus sample or a throat culture, measurement of
      nasal nitric oxide, collection of blood and urine for specimen banking, a CT scan, and lung
      function testing. Children younger than 3 years of age will undergo the scan and lung
      function test under sedation. Children older than 3 years of age will not receive sedation.
      CT scans will be performed at the initial visit and during the visits 3 and 5 for children
      older than 3. For children younger than 3 years, chest CT scans will be performed at the
      initial visit and during visits 4 and 6. Lung function tests and blood and urine collection
      may be repeated at some of the remaining yearly visits. Between yearly visits, parents will
      track on a calendar their children's use of oral, inhaled, and intravenous antibiotics.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Infant lung function</measure>
    <time_frame>Measured at initial study visit (for children under 3)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Spirometry measures</measure>
    <time_frame>Measured yearly for 5 years (after age of 3 years)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory cultures</measure>
    <time_frame>Measured yearly for 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Chest CT scan results</measure>
    <time_frame>Measured at the initial study visit and at Years 3 and 5</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Kartagener Syndrome</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Approximately 2 teaspoons of blood and a small amount of urine (if the child is able to
      urinate in a cup) will be collected and held at the specimen bank located at Denver
      Children's Hospital. These samples will be used to help identify markers that may predict the
      clinical course of PCD.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants in this study will be children younger than 5 years of age who have been
        diagnosed with PCD as based on electron microscopy and/or presence of two known
        disease-causing gene mutations or for whom a diagnosis of PCD has been determined probable
        as based on clinical features and very low nasal nitric oxide (less than 60 nl/minute).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Younger than 5 years of age

          -  Diagnosis of PCD or probable PCD based on criteria listed above

          -  Parent or legal guardian willing to give informed consent

        Exclusion Criteria:

          -  Unable to attend follow-up appointments

          -  History of lung transplant

          -  Any co-existing severe diseases that may have significant impact on lung function,
             respiratory infections, or overall health status (i.e., severe congenital heart
             disease, severe scoliosis, AIDS, cancer, or end-stage kidney disease)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaret W. Leigh, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Margaret Rosenfeld, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Seattle Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University, Palo Alto</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital, Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina, Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital and Regional Medical Center, Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children, Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://rarediseasesnetwork.epi.usf.edu/gdmcc/takeaction/studies/PCD-5903.htm</url>
    <description>Click here for more information about PCD and this study</description>
  </link>
  <reference>
    <citation>Imbrie JD. Kartagener's syndrome: a genetic defect affecting the function of cilia. Am J Otolaryngol. 1981 Aug;2(3):215-22.</citation>
    <PMID>6974512</PMID>
  </reference>
  <reference>
    <citation>Ramotowski R, Guz W, Zieba E, ZÅ‚omaniec G. Clinical and radiological aspects of Kartagener's syndrome. Ann Univ Mariae Curie Sklodowska Med. 2001;56:151-5.</citation>
    <PMID>11977302</PMID>
  </reference>
  <reference>
    <citation>Newmark H 3rd, Willis G, Ablemayor E, Chakmakian V. Kartagener's syndrome seen on CT. Comput Radiol. 1985 Sep-Oct;9(5):279-81.</citation>
    <PMID>3877608</PMID>
  </reference>
  <reference>
    <citation>Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, Nguyen T, Paulus K, Merkel PA; Rare Diseases Clinical Research Network. Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab. 2009 Jan;96(1):20-6. doi: 10.1016/j.ymgme.2008.10.003. Epub 2008 Nov 13.</citation>
    <PMID>19013090</PMID>
  </reference>
  <reference>
    <citation>Lie H, Zariwala MA, Helms C, Bowcock AM, Carson JL, Brown DE 3rd, Hazucha MJ, Forsen J, Molter D, Knowles MR, Leigh MW, Ferkol TW. Primary ciliary dyskinesia in Amish communities. J Pediatr. 2010 Jun;156(6):1023-5. doi: 10.1016/j.jpeds.2010.01.054. Epub 2010 Mar 29.</citation>
    <PMID>20350728</PMID>
  </reference>
  <reference>
    <citation>Olin JT, Burns K, Carson JL, Metjian H, Atkinson JJ, Davis SD, Dell SD, Ferkol TW, Milla CE, Olivier KN, Rosenfeld M, Baker B, Leigh MW, Knowles MR, Sagel SD; Genetic Disorders of Mucociliary Clearance Consortium. Diagnostic yield of nasal scrape biopsies in primary ciliary dyskinesia: a multicenter experience. Pediatr Pulmonol. 2011 May;46(5):483-8. doi: 10.1002/ppul.21402. Epub 2011 Jan 31.</citation>
    <PMID>21284095</PMID>
  </reference>
  <reference>
    <citation>Zariwala MA, Omran H, Ferkol TW. The emerging genetics of primary ciliary dyskinesia. Proc Am Thorac Soc. 2011 Sep;8(5):430-3. doi: 10.1513/pats.201103-023SD. Review.</citation>
    <PMID>21926394</PMID>
  </reference>
  <reference>
    <citation>Leigh MW, O'Callaghan C, Knowles MR. The challenges of diagnosing primary ciliary dyskinesia. Proc Am Thorac Soc. 2011 Sep;8(5):434-7. doi: 10.1513/pats.201103-028SD. Review.</citation>
    <PMID>21926395</PMID>
  </reference>
  <reference>
    <citation>Sagel SD, Davis SD, Campisi P, Dell SD. Update of respiratory tract disease in children with primary ciliary dyskinesia. Proc Am Thorac Soc. 2011 Sep;8(5):438-43. doi: 10.1513/pats.201103-024SD. Review.</citation>
    <PMID>21926396</PMID>
  </reference>
  <reference>
    <citation>Davis SD, Knowles M, Leigh M. Introduction: primary ciliary dyskinesia and overlapping syndromes. Proc Am Thorac Soc. 2011 Sep;8(5):421-2. doi: 10.1513/pats.201103-026SD.</citation>
    <PMID>21926392</PMID>
  </reference>
  <reference>
    <citation>Ostrowski LE, Dutcher SK, Lo CW. Cilia and models for studying structure and function. Proc Am Thorac Soc. 2011 Sep;8(5):423-9. doi: 10.1513/pats.201103-027SD. Review.</citation>
    <PMID>21926393</PMID>
  </reference>
  <reference>
    <citation>Mateos-Corral D, Coombs R, Grasemann H, Ratjen F, Dell SD. Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia. J Pediatr. 2011 Sep;159(3):420-4. doi: 10.1016/j.jpeds.2011.03.007. Epub 2011 Apr 22.</citation>
    <PMID>21514598</PMID>
  </reference>
  <reference>
    <citation>Knowles MR, Leigh MW, Carson JL, Davis SD, Dell SD, Ferkol TW, Olivier KN, Sagel SD, Rosenfeld M, Burns KA, Minnix SL, Armstrong MC, Lori A, Hazucha MJ, Loges NT, Olbrich H, Becker-Heck A, Schmidts M, Werner C, Omran H, Zariwala MA; Genetic Disorders of Mucociliary Clearance Consortium. Mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure. Thorax. 2012 May;67(5):433-41. doi: 10.1136/thoraxjnl-2011-200301. Epub 2011 Dec 18.</citation>
    <PMID>22184204</PMID>
  </reference>
  <reference>
    <citation>Stillwell PC, Wartchow EP, Sagel SD. Primary Ciliary Dyskinesia in Children: A Review for Pediatricians, Allergists, and Pediatric Pulmonologists. Pediatr Allergy Immunol Pulmonol. 2011 Dec;24(4):191-196.</citation>
    <PMID>22276227</PMID>
  </reference>
  <reference>
    <citation>Knowles MR, Leigh MW, Zariwala MA. Cutting edge genetic studies in primary ciliary dyskinesia. Thorax. 2012 May;67(5):464; author reply 464. doi: 10.1136/thoraxjnl-2012-201609. Epub 2012 Feb 10.</citation>
    <PMID>22328589</PMID>
  </reference>
  <reference>
    <citation>Horani A, Druley TE, Zariwala MA, Patel AC, Levinson BT, Van Arendonk LG, Thornton KC, Giacalone JC, Albee AJ, Wilson KS, Turner EH, Nickerson DA, Shendure J, Bayly PV, Leigh MW, Knowles MR, Brody SL, Dutcher SK, Ferkol TW. Whole-exome capture and sequencing identifies HEATR2 mutation as a cause of primary ciliary dyskinesia. Am J Hum Genet. 2012 Oct 5;91(4):685-93. doi: 10.1016/j.ajhg.2012.08.022.</citation>
    <PMID>23040496</PMID>
  </reference>
  <reference>
    <citation>Ferkol TW, Leigh MW. Ciliopathies: the central role of cilia in a spectrum of pediatric disorders. J Pediatr. 2012 Mar;160(3):366-71. doi: 10.1016/j.jpeds.2011.11.024. Epub 2011 Dec 16. Review.</citation>
    <PMID>22177992</PMID>
  </reference>
  <reference>
    <citation>Nakhleh N, Francis R, Giese RA, Tian X, Li Y, Zariwala MA, Yagi H, Khalifa O, Kureshi S, Chatterjee B, Sabol SL, Swisher M, Connelly PS, Daniels MP, Srinivasan A, Kuehl K, Kravitz N, Burns K, Sami I, Omran H, Barmada M, Olivier K, Chawla KK, Leigh M, Jonas R, Knowles M, Leatherbury L, Lo CW. High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy. Circulation. 2012 May 8;125(18):2232-42. doi: 10.1161/CIRCULATIONAHA.111.079780. Epub 2012 Apr 12.</citation>
    <PMID>22499950</PMID>
  </reference>
  <reference>
    <citation>Antony D, Becker-Heck A, Zariwala MA, Schmidts M, Onoufriadis A, Forouhan M, Wilson R, Taylor-Cox T, Dewar A, Jackson C, Goggin P, Loges NT, Olbrich H, Jaspers M, Jorissen M, Leigh MW, Wolf WE, Daniels ML, Noone PG, Ferkol TW, Sagel SD, Rosenfeld M, Rutman A, Dixit A, O'Callaghan C, Lucas JS, Hogg C, Scambler PJ, Emes RD; Uk10k, Chung EM, Shoemark A, Knowles MR, Omran H, Mitchison HM. Mutations in CCDC39 and CCDC40 are the major cause of primary ciliary dyskinesia with axonemal disorganization and absent inner dynein arms. Hum Mutat. 2013 Mar;34(3):462-72. doi: 10.1002/humu.22261. Epub 2013 Feb 11.</citation>
    <PMID>23255504</PMID>
  </reference>
  <reference>
    <citation>Sears PR, Thompson K, Knowles MR, Davis CW. Human airway ciliary dynamics. Am J Physiol Lung Cell Mol Physiol. 2013 Feb 1;304(3):L170-83. doi: 10.1152/ajplung.00105.2012. Epub 2012 Nov 9.</citation>
    <PMID>23144323</PMID>
  </reference>
  <reference>
    <citation>Knowles MR, Leigh MW, Ostrowski LE, Huang L, Carson JL, Hazucha MJ, Yin W, Berg JS, Davis SD, Dell SD, Ferkol TW, Rosenfeld M, Sagel SD, Milla CE, Olivier KN, Turner EH, Lewis AP, Bamshad MJ, Nickerson DA, Shendure J, Zariwala MA; Genetic Disorders of Mucociliary Clearance Consortium. Exome sequencing identifies mutations in CCDC114 as a cause of primary ciliary dyskinesia. Am J Hum Genet. 2013 Jan 10;92(1):99-106. doi: 10.1016/j.ajhg.2012.11.003. Epub 2012 Dec 20.</citation>
    <PMID>23261302</PMID>
  </reference>
  <reference>
    <citation>Ferkol TW, Puffenberger EG, Lie H, Helms C, Strauss KA, Bowcock A, Carson JL, Hazucha M, Morton DH, Patel AC, Leigh MW, Knowles MR, Zariwala MA. Primary ciliary dyskinesia-causing mutations in Amish and Mennonite communities. J Pediatr. 2013 Aug;163(2):383-7. doi: 10.1016/j.jpeds.2013.01.061. Epub 2013 Mar 7.</citation>
    <PMID>23477994</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2008</study_first_submitted>
  <study_first_submitted_qc>July 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2008</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary Ciliary Dyskinesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Dyskinesias</mesh_term>
    <mesh_term>Ciliary Motility Disorders</mesh_term>
    <mesh_term>Kartagener Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

